Different treatment options in COVID cases and role of Favipiravir in mild to moderate cases

Different treatment options in COVID cases and role of Favipiravir in mild to moderate cases

Coronavirus

90 Mins

English Site

Recorded Webinar

Online

Aperçu du cours

 

Cases of COVID-19 are steadily rising in India, and because there is limited clinical experience around treatment options it becomes critical to share knowledge.

Indian Medical Association West Bengal welcomes doctors to a live clinical experience sharing recorded webinar session on “Different treatment options in COVID cases and role of Favipiravir in mild to moderate cases”

Highlights IMA West Bengal 
 
Different treatment options in COVID cases and Role of Favipiravir in mild to moderate cases: Prof. Dr. Jyotirmoy Pal 

●COVID-19 case definitions were explained 
●Triage for patient management according to severity  
●Management of patients with mild symptoms was described   
●Essential investigations for mild cases 
●Features seen on X-Ray in COVID-19 cases 
●Features in progression from mild disease to moderate disease (clinical and laboratory markers) 

Treatment of mild cases (symptomatic and specific) 
Hydroxychroquine: 

●Dosage in treatment and prophylaxis 

Ivermectin: 
●Guidelines and dosage  
●Complications and side effects 
●Evidence regarding use described 

Doxycycline: 
●Usability and complication 
 
Favipiravir:  

●Mechanism of action  
●Indications of use  
●Dosage and complications  
●Side effects and interactions 
●In detail discussion on when to refer to higher centre, when to discharge and regarding follow-up.  
●Guidelines for home isolation 
●6 min walk test procedure explained  

Treatment of moderate case  
●Additional investigations  
●Radiological findings in CT scan 
●Investigations to predict progression explained in detail 
  
Management  

●Oxygen therapy and fluid management
  
Tocilizumab 

●Mechanism of action  
●Indications of use  
●Dosage and complications  
●Side effects and interactions 

Convalescent plasma: ​
●Emergency use approval, Experimental 

Remdesivir  (under emergency use authorization) 
●Mechanism of action  
●Indications of use  
●Dosage and complications  
●Side effects and interactions 

Anticoagulation therapy 
●Whom to start in? 
●What to use? 
●How long to continue? 
●How to estimate Risk Stratification in Hospitals?
 
Heparin  
●Dosage  
●Monitoring during administration
  
Steroids  

●When to use  
●Dosage and precautions   
●Adjustments for comorbid patients  

Question and Answer session  

We thank the Indian Medical Association West Bengal, for hosting this session. We also thank our sponsors Mylan Pharmaceuticals Pvt. Ltd. to make this program possible. Wish you a great learning experience.


Formateurs



Session à venir Du Oct 17, 2020
Au Jan 17, 2021